Identifying ways to increase the proportion of patients with melanoma who have clinically meaningful and durable responses to immune...
Former Vice President Joe Biden returned to the stage at the American Association for Cancer Research (AACR) Annual Meeting...
Now that a plethora of clinical trials have established positive responses from immunotherapies—immune checkpoint inhibitors, in particular—in patients with...
Earlier this week, the U.S. Food and Drug Administration (FDA) approved the molecularly targeted therapeutic niraparib (Zejula) for the...
The U.S. Food and Drug Administration (FDA) has approved expanding the use of the immunotherapeutic pembrolizumab (Keytruda) to include...
The American Association for Cancer Research was shocked last week to learn that the Trump administration has proposed to...
Earlier this week, the U.S. Food and Drug Administration approved the molecularly targeted therapeutic ribociclib (Kisqali) for use in...
January is Cervical Cancer Awareness Month. It’s a time to celebrate progress against a disease that was once a...
Experts identify opportunities and challenges facing cancer researchers in 2017.
A look at the 10 most-read posts of the year on Cancer Research Catalyst illustrates the steady pace of...